Compositions and methods for treatment of asthma
US6630140B1 · kind B1 · utility
34Cited by
4References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 1999 |
| Grant date | Oct 7, 2003 |
| Priority date | — |
| Expiry date | Mar 3, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/54
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating or preventing induction of asthma in a human patient are provided. The methods comprise administering to the human an anti-Fc&egr;RII receptor protein ligand suspended in a pharmaceutically acceptable carrier in an amount sufficient to inhibit binding of IgE to an anti-Fc&egr;RII receptor protein thereby treating or preventing induction of asthma in the human.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.